|
| Scientific Program |
| |
|
| Scientific Program | Search Abstract |
| |
|
|
| Session |
| |
| Myeloproliferative disorders - Clinical |
| Date: |
Saturday, 06 June 2009
|
| Time: | 18:00-19:15 |
| Room: | |
| |
| 18:00-19:15 |
|
INCREASED RISK OF LYMPHOID MALIGNANCIES IN PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
| 0645 |
| Antonioli, Elisabetta,
Susini, M.C.,
Masala, G.,
Guglielmelli, P.,
Pieri, L.,
Caini, S.,
Palli, D.,
Bogani, C.,
Pancrazzi, A.,
Longo, G.,
Bosi, A.,
Vannucchi, A.M.
(Florence, Italy) |
| |
| 18:00-19:15 |
|
THE LONG-TERM DURABILITY OF MOLECULAR RESPONSES IN PATIENTS WITH FIP1L1-PDGFRA CHRONIC HEOSINOPHILIC LEUKEMIA TREATED WITH IMATINIB: THE ITALIAN HES0203 EXPERIENCE AFTER A 4-YEAR FOLLOW-UP
| 0646 |
| Rondoni, Michela,
Cilloni, Daniela,
Paolini, Stefania,
Ottaviani, Emanuela,
Messa, Francesca,
Piccaluga, Pier Paolo,
Merante, Serena,
Buccisano, Francesco,
Titibelli, Mario,
Vigna, Ernesto,
Spadea, Antonio,
Messa, Emanuela,
Pane, Fabrizio,
Saglio, Giuseppe,
Lauria, Francesco,
Baccarani, Michele,
Martinelli, Giovanni
(Siena, Italy) |
| |
| 18:00-19:15 |
|
REDUCED SURVIVAL IN PATIENTS WITH PRIMARY MYELOFIBROSIS IS PREDICTED BY A LOW BURDEN OF JAK2V617 MUTATED ALLELE
| 0647 |
| Guglielmelli, Paola,
Barosi, G.,
Specchia, G.,
Rambaldi, A.,
Lo-Coco, F.,
Antonioli, E.,
Pieri, L.,
Pancrazzi, A.,
Ponziani, V.,
Delaini, F.,
Ammatuna, E.,
Liso, V.,
Bosi, A.,
Barbui, T.,
Vannucchi, A.M.
(Florence, Italy) |
| |
| 18:00-19:15 |
|
POMALIDOMIDE IN MYELOFIBROSIS: RESULTS OF A PHASE-1 DOSE-SEEKING TRIAL
| 0648 |
| Mesa, Ruben,
Pardanani, Animesh,
Hussein, Kebede,
Gale, Robert,
Schwager, Susan,
Litzow, Mark,
Hogan, William,
Tefferi, Ayalew
(Rochester, United States of America) |
| |
| 18:00-19:15 |
|
PRIMARY AND SECONDARY RESISTANCE TO IMATINIB IS VERY RARE IN CHRONIC AND BLAST PHASE OF MYELOPROLIFERATIVE NEOPLASMS WITH REARRANGEMENTS OF PDGFRA AND PDGFRB
| 0649 |
| Metzgeroth, Georgia,
Erben, Philipp ,
Walz, Christoph,
Gosenca, Darco,
Mix, Jürgen,
Haferlach, Claudia,
Schnittger, Susanne ,
Cross, Nicholas C.P.,
Hochhaus, Andreas,
Reiter, Andreas (P)
(Mannheim, Germany) |
| |
| 18:00-19:15 |
|
MYELOFIBROSIS AND REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (RISCT)
| 0650 |
| Popat, Uday,
Rondon, G.,
Alousi, A.,
Anderlini, P.,
Andersson, B.,
Hosing, C.,
De Lima, M.,
Giralt, S.,
Kebriaei, P.,
Nieto, Y.,
Khouri, I.,
Qazibash, M.,
Jones, R.,
Champlin, R.
(Houston, United States of America) |
| |
| 18:00-19:15 |
|
THE EVALUATION OF XAGRID EFFICACY AND LONG-TERM SAFETY STUDY: MONITORING SAFETY OUTCOMES IN AT-RISK ESSENTIAL THROMBOCYTHAEMIA (ET) PATIENTS TREATED WITH ANAGRELIDE VS OTHER CYTOREDUCTIVE THERAPIES
| 0651 |
| Birgegård, Gunnar ,
Besses, Carlos,
Coll, Ruth,
Freitag, Chris,
Griesshammer, Martin,
Gugliotta, Luigi,
Harrison, Claire,
Kiladjian, Jean-Jacques
(Uppsala, Sweden) |
| |
| 18:00-19:15 |
|
LIVING WITH ESSENTIAL THROMBOCYTHEMIA IN FRANCE: PROSPECTIVE SURVEY ASSESSING DAILY LIFE DISEASE IMPACT IN 245 PATIENTS
| 0652 |
| Rey, Jérôme,
De Revel, Thierry,
Lenain, Pascal,
Raffoux, Emmanuel,
Kiladjian, Jean-Jacques
(Marseille, France) |
| |
| 18:00-19:15 |
|
APLIDIN IMPROVES MEGAKARYOCYTOPOIESIS AND HALTS NEO-ANGIOGENESIS IN THE GATA1(LOW) MURINE MODEL OF MYELOFIBROSIS
| 0653 |
| Verrucci, Maria,
Pancrazzi, Alessandro,
Paz, Maria Fe,
Martelli, Fabrizio,
Guglielmelli, Paola,
Aracil, Miguel,
Zingariello, Maria,
D'Amore, Emanuela,
Jimeno, Josè,
Vannucchi, Alessandro Maria,
Migliaccio, Anna Rita
(Rome, Italy) |
| |
| 18:00-19:15 |
|
EFFICACY OF LENALIDOMIDE IN PATIENTS WITH MYELOFIBROSIS: SPANISH COMPASSIONATE USE PROGRAM. PRELIMINARY ANALYSIS
| 0654 |
| Castillo, Inmaculada,
Ojeda, Ana Mª,
Boqué, Concha,
Asensio, Agustín,
Hermosilla, Mª del Mar,
Blanes, Margarita,
Busto, Josefa,
Carrasco, Vicente,
Cuesta, Isabel,
Echeveste, Mª Asunción,
Fernández-Miñano, Carmen,
García-Sánchez, Pedro,
Gil, Juan José,
Hernández, Francisca,
Ibañez, Ángela,
Lemes, Angelines,
Ramírez, Angel,
Silvana, Daniela,
Somolinos, Nieves,
Monteagudo, Mª Dolores,
Ulibarrena, Carlos,
Borrego, Domingo
(Elda - Alicante, Spain) |
| |
| 18:00-19:15 |
|
JAK2 V617F-POSITIVE CHRONIC EOSINOPHILIC LEUKEMIA: CLINICAL, LABORATORY AND MOLECULAR DEFINITION OF A DISTINCT DISEASE SUBTYPE
| 0655 |
| Zoi, Katerina,
Dahabreh, Issa (P),
Zoi, Christine,
Helbig, Grzegorz ,
Krzemien, Slawomira ,
Gota, Vaia,
Speletas, Matthaios ,
Giannouli, Stavroula,
Palliou, Andrianna,
Stefanoudaki, Katy,
Harhalakis, Nicholas ,
Vassilopoulos, George,
Kotsopoulou, Maria,
Tsirigotis, Panagiotis ,
Moutsopoulos, Haralampos,
Loukopoulos, Dimitris,
Voulgarelis, Michael
(Athens, Greece) |
| |
| 18:00-19:15 |
|
UK SYSTEMIC MASTOCYTOSIS REGISTRY: ANALYSIS OF DATA ON 71 CASES
| 0656 |
| Myers, Bethan,
Marks, Sasha,
Thomson, Jennifer,
Poynton, Christopher,
Shepherd, Pat,
Cullis, Jonathan,
Radia, Deepti
(Nottingham, United Kingdom) |
| |
| 18:00-19:15 |
|
POLYCYTHEMIA VERA AS A PREDISPOSING FACTOR FOR AORTIC STENOSIS: INCIDENCE AND CORRELATION WITH BLOOD CELLS COUNT AND MUTATIONAL STATUS
| 0657 |
| Siragusa, Sergio,
Barone, Rita (P),
Caracciolo, Clementina,
Di Maggio, Rosario,
Fazio, Giovanni,
D'Angelo, Luciana,
Montana, Maria,
Caramazza, Domenica,
Malato, Alessandra,
Saccullo, Giorgia,
Pizzo, G.,
Casuccio, Alessandra,
Novo, Salvatore,
Abbadessa, Vincenzo
(Palermo, Italy) |
| |
| 18:00-19:15 |
|
DASATINIB FOR THE TREATMENT OF TREATMENT-REFRACTORY HYPEREOSINOPHILIC SYNDROME AND CHRONIC EOSINOPHILIC LEUKEMIA
| 0658 |
| Dahabreh, Issa,
Giannouli, Stavroula,
Zoi, Christine,
Gota, Vaia,
Leondaritis, George,
Sambani, Constantina ,
Loukopoulos, Dimitris,
Voulgarelis, Michael,
Zoi, Katerina
(Athens, Greece) |
| |
| 18:00-19:15 |
|
HIGH RESOLUTION MELTING CURVE ANALYSIS: A SIMPLE, RELIABLE AND SENSITIVE METHOD OF DETECTION OF JAK2 EXON 12 MUTATIONS
| 0659 |
| Lavabre-Bertrand, Thierry,
Carillo, Serge,
Henry, Laurent,
Lippert, Eric,
Girodon, François,
Guiraud, Isabelle,
Richard, Céline,
Cleyrat, Cédric,
Jourdan, Eric,
Kravlovics, Robert,
Hermouet, Sylvie
(Nimes, France) |
| |
| 18:00-19:15 |
|
EXPRESSION OF A SET OF CELL-STROMA INTERACTING GENES IN PATIENTS WITH PRIMARY MYELOFIBROSIS
| 0660 |
| Livun, Ana,
Manshouri, Taghi,
Kusec, Rajko (P),
Zhang, Ying,
Kantarjian, Hagop M.,
Verstovsek, Srdjan
(Houston, United States of America) |
| |
| 18:00-19:15 |
|
THE IMPACT OF AZACITIDINE AND DECITABINE (HYPOMETHYLATING-AGENTS) IN MYELODYSPLASTIC SYNDROMES: A SYSTEMATIC REVIEW AND META-ANALYSIS
| 0661 |
| Kumar, Ambuj,
List, Alan,
Hozo, Iztok,
Djulbegovic, Benjamin
(Tampa, United States of America) |
| |
| 18:00-19:15 |
|
PRESENCE OF JAK2 V617F MUTATION IS A SINGLE STRONG PREDICTOR OF VASCULAR COMPLICATIONS IN PATIENTS WITH MPD
| 0662 |
| Quitt, Miriam,
Gedzun, Ludmila,
Shabad, Evelyn,
Kotler, Antonio,
Valkovsky, Olga,
Ballan, Mouna,
Shusterman, Taly,
Mishchenko, Elena,
Lindenfeld, Noemi,
Cassel, Aliza
(Haifa, Israel) |
| |
| 18:00-19:15 |
|
JAK2 V617F MUTATION IN ACUTE MYELOID LEUKEMIA SECONDARY TO PH NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS
| 0663 |
| Rinaldi, Ciro Roberto,
Rinaldi, Paola,
Martinelli, Vincenzo,
Ciancia, Rosanna,
Vannucchi, Alessandro Maria,
Gugliotta, Luigi,
Barbui, Tiziano,
Rotoli, Bruno,
Pane, Fabrizio
(Naples, Italy) |
| |
| 18:00-19:15 |
|
STUDY OF THE RELATION BETWEEN THE TIME COURSE OF THE JAK2V617F ALLELE BURDEN AND THE CLINICAL OUTCOME IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS (MPNS); A SINGLE CENTER STUDY
| 0664 |
| Sobas, Marta,
Perez-Encinas, M.M.,
Quinteiro, C.,
Gonzalez, T.,
Suarez, S.,
Vilariño, D.,
Alonso, N.,
Diaz, J.,
Bendaña, A.,
Gonzalez, S.,
Bello-Lopez, J.L.
(Santiago De Compostela, Spain) |
| |
|